Perfil
Carrie L.
Bourdow is currently the Chairman & Chief Executive Officer at Trevena, Inc. She previously served as an Independent Director at Sesen Bio, Inc. from 2020 to 2023 and at Nabriva Therapeutics Plc from 2017 to 2023.
Prior to that, she was the Vice President-Marketing at Cubist Pharmaceuticals LLC from 2013 to 2015.
Ms. Bourdow holds an undergraduate degree from Hendrix College and an MBA from Southern Illinois University.
Cargos activos de Carrie Bourdow
| Empresas | Cargo | Inicio |
|---|---|---|
| TREVENA, INC. | Director Ejecutivo | 01/10/2018 |
Antiguos cargos conocidos de Carrie Bourdow.
| Empresas | Cargo | Fin |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Director/Miembro de la Junta | 30/07/2023 |
| CARISMA THERAPEUTICS, INC. | Director/Miembro de la Junta | 07/03/2023 |
| CUBIST PHARMACEUTICALS INC | Ventas & Marketing | 01/05/2015 |
Formación de Carrie Bourdow.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Hendrix College
Hendrix College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern Illinois University
Southern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
- Bolsa de valores
- Insiders
- Carrie Bourdow
















